Clinical Trial Update: Efficacy and Safety of Belimumab in SLE Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of belimumab in systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: RenJi Hospital | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED